Product Information

CODEINE SULFATE 30 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.7348 per EA under NDC 00054024425. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Jul 16, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CODEINE SULFATE 30 MG TABLET

codeine sulfate
$0.7348per EA
DEA Schedule CII

Strength

30 mg/1

NDC

00054024425

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CODEINE SULFATE

Approval Type

New Drug (NDA)

FDA Application

NDA022402

FDA Approved

7/16/2009

TE Code

AB

On Market Since

7/16/2009

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for CODEINE SULFATE 30 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has risen 92.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7348 per EA
All-time high$0.7484 (Dec 14, 2022)
All-time low$0.3243 (May 23, 2018)
52-week high$0.7458
52-week low$0.6563
Median price$0.5122
Average price$0.5153
Largest weekly change+41.5% (Jan 20, 2021)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-1.5%

1M

+1.1%

3M

+5.7%

6M

+10.4%

1Y

+10.9%

3Y

+22.3%

5Y

+10.2%

All

+92.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CODEINE SULFATE 30 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CODEINE SULFATE 30 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.7348 per EA (NDC 00054024425), effective Nov 18, 2026.

How has the price of CODEINE SULFATE 30 MG TABLET changed over time?

Over the history we have for it, the NADAC for CODEINE SULFATE 30 MG TABLET has risen 92.1%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CODEINE SULFATE 30 MG TABLET?

Since Nov 28, 2013, the NADAC for CODEINE SULFATE 30 MG TABLET has ranged from a low of $0.3243 (May 23, 2018) to a high of $0.7484 (Dec 14, 2022), with a median of $0.5122 per EA.

Are there cheaper alternatives to CODEINE SULFATE 30 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CODEINE SULFATE 30 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CODEINE SULFATE 30 MG TABLET?

CODEINE SULFATE 30 MG TABLET (NDC 00054024425) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.